Myelofibrosis (MF) Video Channel
Explore the latest insights and summaries from experts in Myelofibrosis (MF).
Recommended for You
Loading...
Trending Videos This Week
Loading...
Treatment Landscape
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: MPN Highlights and Clinical Implications
FEATURING
Douglas Tremblay
- 506 views
- December 18, 2024
- 1
2024 ASH Annual Meeting Insights Hub
ASH 2024 Summary: Pegylated Interferon in MPN - The Who, Why, and How
FEATURING
Jean-Jacques Kiladjian
- 215 views
- December 17, 2024
- 4
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
FEATURING
Ayalew Tefferi
- 1,392 views
- May 3, 2024
- 13
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in Heme Malignancies
FEATURING
Maria Gomes da Silva
- 553 views
- September 23, 2024
- 2
MyCancerHaven
Experts Discuss How They Choose 2L Therapy in MF
FEATURING
Ravi Vij,
Prithviraj Bose
- 167 views
- August 30, 2024
GRACE
Approach to Selecting Treatment for Myelofibrosis in 2024
FEATURING
Andrew Srisuwananukorn
- 61 views
- November 25, 2024
The University of Kansas Cancer Center
Prioritizing Overall Survival in MF: Longterm Updates From COMFORT-I and II Studies
FEATURING
Abdulraheem Yacoub
- 59 views
- December 16, 2024
Insights from 2024 EHA Annual Meeting
Top 5 Impactful MPN Abstracts From Summer Conferences
FEATURING
Prithviraj Bose
- 159 views
- July 31, 2024
UChicago Medicine
Overview of Recent Updates in MPNs and MDS
FEATURING
Satyajit Kosuri
- 335 views
- March 20, 2024
- 3
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
2024 Updates in Myeloproliferative Neoplasms
FEATURING
Elizabeth Hexner
- 319 views
- March 3, 2024
- 1
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of MPNs - Highlights & Key Takeaways"
FEATURING
Ruben Mesa
- 367 views
- January 19, 2024
- 3
Winship Cancer Institute - Emory University
Updates on Myeloproliferative Neoplasms Including CML
FEATURING
Anthony Hunter
- 152 views
- May 7, 2024
City of Hope
Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Targeted Strategies
FEATURING
Idoroenyi Amanam
- 219 views
- March 11, 2024
- 1
Total Health
West Oncology Conference: Overview and Updates in MPNs
FEATURING
Jason Chandler
- 113 views
- January 8, 2024
Louisville Hematology Highlights
Is a Bigger Induction "Hammer" Necessarily Better in Today's Stem Cell Transplantation?
FEATURING
William Tse
- 116 views
- February 27, 2024
- 1
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Updates in the Prognosis and Treatment of Myelofibrosis
FEATURING
Selami Koçak Toprak
- 32 views
- February 21, 2024
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Future Directions in the Management of Myelofibrosis
FEATURING
Andrew Kuykendall
- 93 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Managing Accelerated and Blast Phase MPN
FEATURING
Olatoyosi Odenike
- 66 views
- October 10, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: Myeloproliferative Neoplasms - A Look Into the Future
FEATURING
Rami Komrokji
- 31 views
- November 27, 2023
Therapeutic Agents
Yale Cancer Center
Myeloid Malignancies: Hot Topics in 2024
FEATURING
Nikolai Podoltsev
- 337 views
- October 21, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Current and Future Treatment Landscape of Myelofibrosis
FEATURING
Rami Komrokji
- 208 views
- October 8, 2024
- 1
16th International Congress on Myeloproliferative Neoplasms
Novel Agents for MPNs in 2024
FEATURING
Naveen Pemmaraju
- 143 views
- December 3, 2024
- 1
Winship Cancer Institute - Emory University
COMFORT-1 Trial Long-Term Follow-Up: Impact of Ruxolitinib on OS for Myelofibrosis Patients
FEATURING
Anthony Hunter
- 137 views
- December 31, 2024
16th International Congress on Myeloproliferative Neoplasms
Selection of JAK1/2 Inhibitors for Primary Myelofibrosis
FEATURING
Aaron Gerds
- 96 views
- December 3, 2024
Vanderbilt University Medical Center (VUMC)
Management of MF After Ruxolitinib Failure
FEATURING
Ashwin Kishtagari
- 221 views
- July 18, 2024
- 2
Alexander Coltoff
Survival as a Primary Goal in MF: Evaluating 5-Yr Data From COMFORT-1
- 121 views
- November 5, 2024
UChicago Medicine
Current Management of Accelerated/Blast-Phase MPNs
FEATURING
Anand Patel
- 81 views
- October 25, 2024
- 1
16th International Congress on Myeloproliferative Neoplasms
Clinical and Therapeutic Aspects of Chronic Inflammation in the MPNs
FEATURING
Hans Hasselbalch
- 61 views
- November 26, 2024
- 1
MyCancerHaven
Experts Discuss Their Current Approach to Treating MF
FEATURING
Ravi Vij,
Abdulraheem Yacoub
- 134 views
- August 30, 2024
Indy Hematology Review
2024 Updates on Myelofibrosis and Systemic Mastocytosis
FEATURING
Raajit Rampal
- 368 views
- April 16, 2024
- 1
Memorial Sloan Kettering Cancer Center
Key Updates in AML, MDS, & MF From ASH
FEATURING
Aaron Goldberg
- 316 views
- May 2, 2024
- 4
Moffitt Cancer Center
Current Treatment Landscape of JAK Inhibitors in MF
FEATURING
Andrew Kuykendall
- 243 views
- May 13, 2024
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Implications"
FEATURING
Douglas Tremblay
- 410 views
- January 26, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Ph3 BOREAS Study - Navtemadlin vs. Best Available Therapy in JAK Inhibitor R/R MF
FEATURING
John Mascarenhas
- 38 views
- December 27, 2024
Yale Cancer Center
Emerging Therapies in MF & PV: Insights From Recent Clinical Trials
FEATURING
Jan Bewersdorf
- 176 views
- May 14, 2024
- 1
Mary Frances McMullin
Quality of Life in Myelofibrosis Patients Treated With Momelotinib
- 220 views
- April 26, 2024
SOHO Highlights: State of the Art and Next Questions
State of the Art and Next Questions: MPN
FEATURING
John Mascarenhas
- 271 views
- March 22, 2024
Akhil Jain
Overview of Myelofibrosis: Management, JAK Inhibitor Trials, and Emerging Therapies
- 25 views
- January 31, 2025
Prithviraj Bose
MANIFEST-2 Study: Pelabresib With Ruxolitinib for JAKi-Naïve Patients With Myelofibrosis
- 225 views
- April 22, 2024
- 1
Insights from 2023 ASH Annual Meeting
Prevalence and Prediction of Ruxolitinib Treatment Emergent Thrombocytopenia in Myelofibrosis
FEATURING
Douglas Tremblay
- 436 views
- December 13, 2023
- 1
Cleveland Clinic Taussig Cancer Institute
Updates in MPNs From ASH 2023
FEATURING
Rebecca B. Klisovic
- 15 views
- October 22, 2024
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Addressing Anemia in Myelofibrosis
FEATURING
Stephen Oh
- 229 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Novel Non-JAK Inhibitor Therapies for Myelofibrosis
FEATURING
John Mascarenhas
- 233 views
- October 10, 2023
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Advances and Unmet Needs in MPN Treatment
FEATURING
Daniela Cilloni
- 82 views
- February 21, 2024
Icahn School of Medicine at Mount Sinai
Strategies to Overcome Immune Dysregulation in MPNs
FEATURING
Cansu Cimen Bozkus
- 33 views
- July 2, 2024
Jeanne Palmer
Momelotinib in MF: Insights from SIMPLIFY-1, SIMPLIFY-2, and MOMENTUM Trials
- 34 views
- January 30, 2025
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Management of Myelofibrosis in Special Patient Populations
FEATURING
John Mascarenhas
- 151 views
- October 9, 2023
Icahn School of Medicine at Mount Sinai
Stem Cell Pathways, Aging, and Cancer Evolution in MPN
FEATURING
Catriona Jamieson
- 25 views
- July 2, 2024
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Clinical Decision-Making for Patients With Myelofibrosis
FEATURING
Prithviraj Bose
- 77 views
- October 18, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Choosing and Properly Using a JAK Inhibitor in Myelofibrosis
FEATURING
Anthony Hunter
- 96 views
- October 16, 2023
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: Myeloproliferative Neoplasms
FEATURING
John Mascarenhas
- 67 views
- October 19, 2023
- 1
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "PIM1 Kinase Inhibitor TP-3654 for R/R Myelofibrosis"
FEATURING
Lindsay Rein
- 40 views
- December 19, 2023
Diagnostics & Biomarkers
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for Myeloproliferative Neoplasms
FEATURING
Ayalew Tefferi
- 1,574 views
- April 23, 2024
- 10
16th International Congress on Myeloproliferative Neoplasms
Allele Burden in MPN: Practical Considerations
FEATURING
Raajit Rampal
- 221 views
- November 26, 2024
- 1
University of Colorado Division of Hematology
2024 Updates in MF
FEATURING
Brandon McMahon
- 78 views
- April 19, 2024
- 1
16th International Congress on Myeloproliferative Neoplasms
The Importance of Chromosomes in MPN in 2024
FEATURING
Vesna Najfeld
- 20 views
- December 4, 2024
5th SOHO Italy Annual Conference
SOHO Italy 2023: Diagnosis and Prognosis of MPNs in the Precision Oncology Era
FEATURING
Tariq Mughal
- 46 views
- November 27, 2023
- 1
SOHO 2023 Eleventh Annual Meeting
SOHO 2023: Modern Prognostication in Classic MPNs
FEATURING
Francesco Passamonti
- 50 views
- October 18, 2023
Disease Overview
Akhil Jain
Overview of Myelofibrosis: Pathogenesis, Diagnosis, and Prognostic Models
- 11 views
- January 31, 2025
16th International Congress on Myeloproliferative Neoplasms
MPNs in Children, Adolescents, and Young Adults
FEATURING
Nicole Kucine
- 25 views
- December 5, 2024
16th International Congress on Myeloproliferative Neoplasms
Polycythemia Vera Progression: Prevention and Prediction
FEATURING
Ghaith Abu-Zeinah
- 16 views
- December 4, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Key Biological and Clinical Developments in MPNs
FEATURING
Tariq Mughal
- 113 views
- February 16, 2024
MyCancerHaven
Experts Discuss the Diagnosis & Management of Myelofibrosis
FEATURING
Ravi Vij,
Stephen Oh
- 138 views
- November 16, 2023
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Retrospective Analysis of Primary MF Patients in Azerbaijan
FEATURING
Elmir Guluyev
- 15 views
- September 16, 2024
5th SOHO Italy Annual Conference
SOHO Italy 2023: WHO 2022 Classification of MPNs - Transitioning From the Optical Into the Molecular Era
FEATURING
Hanan Hamed
- 25 views
- November 27, 2023
5th SOHO Italy Annual Conference
SOHO Italy 2023: A New Pathogenetic Paradigm for Myeloproliferative Neoplasms - The “Circulating Wound”
FEATURING
Alessandro Lucchesi
- 16 views
- November 27, 2023
Case Studies
16th International Congress on Myeloproliferative Neoplasms
Predictors of Allogeneic Transplantation Outcome in Primary Myelofibrosis
FEATURING
Koen van Besien
- 55 views
- November 26, 2024
Integrity CE
Collaborative Care in MF - Community and Academic Physicians Discuss Managing a Complicated Case
FEATURING
Luke Fletcher,
Aaron Gerds
- 128 views
- January 24, 2024
Icahn School of Medicine at Mount Sinai
Targeting Mutant Calreticulin in MPN
FEATURING
Ann Mullally
- 53 views
- July 2, 2024
- 1
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Myelofibrosis Case Discussion: Patient With Splanchnic Venous Thrombosis
FEATURING
Weronika Lebowa
- 19 views
- September 25, 2024
5th SOHO Italy Annual Conference
SOHO Italy 2023: Pregnancy in MPNs - How to Manage These Patients
FEATURING
Elisabetta Abruzzese
- 35 views
- November 27, 2023
GRACE
Myeloproliferative Neoplasms 101: Epidemiology, Etiology, and Diagnosis
FEATURING
Andrew Srisuwananukorn
- 2 views
- February 6, 2025